Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Peer Review channel feed
Exclusive: Affini-T taps Sanofi alum to lead hunt for partnerships; Alkermes locks in CEO for oncology spinout
Last year
Stephen Hahn’s cancer-testing biotech hires a new CMO; Former Iovance exec named CEO of Obsidian
Last year
Vir enlists J&J vet to run business development; Gilead finds Kite successor to Christi Shaw
Last year
Astellas president jumps to a new Frontier; Grifols chairman named CEO, breaking family tradition
Last year
Maria Fardis ends a two-year CEO hiatus; More leadership turnover on the menu at Galapagos
3 years ago
'Inspired' by Ipsen's mission, Sandra Silvestri joins as next CMO; Exicure's slide continues with CEO, CFO exits
3 years ago
Amylyx welcomes former Alnylam exec to help expand Relyvrio; Amarin plugs in an interim chief
3 years ago
Legend's new CMO will bring in more cell therapy partners; Precision founders get back in Tune together
3 years ago
After decades in Big Pharma, Kelly Page heads to 'growth stage'; Allied with Novartis, Bicycle selects development chief
3 years ago
Jim Mullen scours private equity deals amid biotech winter; Ex-AbbVie medical chief succeeds Briggs Morrison at Syndax
3 years ago
Three's a crowd as another Kite exec hits the exit; Surfing tough waters, Celyad Oncology picks up new CEO
3 years ago
Ultragenyx adds new CMO with internal promotion; Autolus CFO to leave for MorphoSys — but not quite yet
3 years ago
Biogen looks to its bench to replace chairman Papadopoulos; Lilly, AbbVie gene therapy partner makes CSO hire
3 years ago
Kymera's top drug hunter leaves for Alexis Borisy's Curie.Bio; What’s done is Dunn: FDA neuroscience leader bows out
3 years ago
Art Levin trades the C-suite for pair of roles at Avidity; Ex-Merck CEO Ken Frazier to chair another company
3 years ago
Au revoir, Sanofi: John Reed dashes to J&J; Zentalis plucks new COO from GSK
3 years ago
Bayer, Astellas gear up for next CEOs; Ex-AMAG chief Scott Myers resurfaces at Viridian
3 years ago
After 13 years, Ramy Mahmoud steps into CEO seat at Optinose; Rupert Vessey set to exit Bristol Myers in July
3 years ago
Exclusive: Cell therapy biotech brings on Loxo vet amid global expansion plans; Retirement beckons for Vir's George Scangos
3 years ago
'Perfect time': SIGA's CEO on retirement; Juvenescence woos GSK vet to lead anti-aging play
3 years ago
Novavax and CureVac among several biotechs with new CEOs; Michel Vounatsos, John Tsai land board appointments
3 years ago
Biogen names development chief as it braces for lecanemab decision; Zymeworks CMO is shown the door
3 years ago
Alex Harding to chase industry dreams at CRISPR Therapeutics; Scoop: Biogen’s head of business development splits for Kite
3 years ago
Hemgenix now approved, Paul Perreault plans his exit from CSL; LianBio president hands in resignation
3 years ago
First page
Previous page
2
3
4
5
6
7
8
Next page
Last page